Department of Critical Care and Emergency Medicine and The CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute illness) Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Crit Care Med. 2012 Oct;40(10):2788-96. doi: 10.1097/CCM.0b013e31825b8ade.
To determine whether benzodiazepine and propofol doses are increased at night and whether daytime and nighttime sedative doses are associated with delirium, coma, and delayed liberation from mechanical ventilation.
Single-center, prospective cohort study nested within the Awakening and Breathing Controlled randomized trial.
Saint Thomas Hospital in Nashville, TN, from 2004 to 2006.
Adult patients receiving mechanical ventilation for >12 hrs with continuous recording of hourly sedation dosing.
We measured hourly doses of benzodiazepine and propofol exposure during the daytime (7 AM to 11 PM) and nighttime (11 PM to 7 AM) for 5 days. We quantified nighttime dose increases by subtracting the average hourly daytime dose on the preceding day from subsequent average hourly nighttime dose. We used multivariable logistic regression to determine whether daytime and nighttime dose increases were independently associated with delirium, coma, and delayed liberation from mechanical ventilation.
Among 140 patients, the median Acute Physiology and Chronic Health Evaluation II score was 27 (interquartile range 22-33). Among those receiving the sedatives, benzodiazepine and propofol doses were increased at night on 40% and 41% of patient-days, respectively. Of 485 patient-days, delirium was present on 160 (33%) and coma on 206 (42%). In adjusted models, greater daytime benzodiazepine dose was independently associated with failed spontaneous breathing trial and extubation, and subsequent delirium (p<.02 for all). Nighttime increase in benzodiazepine dose was associated with failed spontaneous breathing trial (p<.01) and delirium (p=.05). Daytime propofol dose was marginally associated with subsequent delirium (p=.06).
Nearly half of mechanically ventilated intensive care unit patients received greater doses of sedation at night, a practice associated with failed spontaneous breathing trials, coma, and delirium. Over the first 5 days in our study, patients spent 75% of their time in coma or delirium, outcomes that may be reduced by efforts to decrease sedative exposure during both daytime and nighttime hours in the intensive care unit.
确定苯二氮䓬类药物和丙泊酚的剂量是否在夜间增加,以及白天和夜间的镇静剂量是否与谵妄、昏迷和延迟脱离机械通气有关。
嵌套在觉醒和呼吸控制随机试验中的单中心前瞻性队列研究。
田纳西州纳什维尔的圣托马斯医院,时间为 2004 年至 2006 年。
接受机械通气>12 小时的成年患者,连续记录每小时镇静剂量。
我们测量了 5 天内白天(7 点至 11 点)和夜间(11 点至 7 点)每小时苯二氮䓬类药物和丙泊酚的暴露剂量。我们通过从前一天的平均每小时日间剂量中减去随后的平均每小时夜间剂量来量化夜间剂量的增加。我们使用多变量逻辑回归来确定日间和夜间剂量的增加是否与谵妄、昏迷和延迟脱离机械通气独立相关。
在 140 名患者中,急性生理学和慢性健康评估 II 评分中位数为 27(四分位距 22-33)。在接受镇静剂的患者中,分别有 40%和 41%的患者日夜间剂量增加。在 485 个患者日中,160 个(33%)出现谵妄,206 个(42%)出现昏迷。在调整后的模型中,日间苯二氮䓬类药物剂量增加与自主呼吸试验失败和拔管以及随后的谵妄独立相关(所有 p<.02)。苯二氮䓬类药物夜间剂量增加与自主呼吸试验失败(p<.01)和谵妄(p=.05)有关。日间丙泊酚剂量与随后的谵妄有边缘相关性(p=.06)。
近一半的机械通气重症监护病房患者夜间接受了更大剂量的镇静剂,这种做法与自主呼吸试验失败、昏迷和谵妄有关。在我们的研究中,患者在前 5 天内有 75%的时间处于昏迷或谵妄状态,通过减少重症监护病房白天和夜间镇静剂暴露量,可能会降低这些不良结局的发生率。